These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 12773120)

  • 21. Insulin inhibition of proteasome activity in intact cells.
    Hamel FG; Bennett RG; Harmon KS; Duckworth WC
    Biochem Biophys Res Commun; 1997 May; 234(3):671-4. PubMed ID: 9175773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures.
    Bennett RG; Hamel FG; Duckworth WC
    Diabetes; 2003 Sep; 52(9):2315-20. PubMed ID: 12941771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme.
    Authier F; Rachubinski RA; Posner BI; Bergeron JJ
    J Biol Chem; 1994 Jan; 269(4):3010-6. PubMed ID: 8300632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.
    Fawcett J; Permana PA; Levy JL; Duckworth WC
    Arch Biochem Biophys; 2007 Dec; 468(1):128-33. PubMed ID: 17964527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-degrading enzyme hydrolyzes ATP.
    Del Carmen Camberos M; Cresto JC
    Exp Biol Med (Maywood); 2007 Feb; 232(2):281-92. PubMed ID: 17259336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of insulin domains important for binding to and degradation by endosomal acidic insulinase.
    Authier F; Danielsen GM; Kouach M; Briand G; Chauvet G
    Endocrinology; 2001 Jan; 142(1):276-89. PubMed ID: 11145591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.
    Tawa NE; Odessey R; Goldberg AL
    J Clin Invest; 1997 Jul; 100(1):197-203. PubMed ID: 9202072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-degrading enzyme is capable of degrading receptor-bound insulin.
    Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Amano K; Sakamoto T; Kawase Y; Akiyama H; Nagata M
    Biochem Biophys Res Commun; 1988 Jan; 150(2):605-14. PubMed ID: 3277630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution.
    Sbardella D; Tundo GR; Sciandra F; Bozzi M; Gioia M; Ciaccio C; Tarantino U; Brancaccio A; Coletta M; Marini S
    PLoS One; 2015; 10(7):e0132455. PubMed ID: 26186340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.
    Maianti JP; McFedries A; Foda ZH; Kleiner RE; Du XQ; Leissring MA; Tang WJ; Charron MJ; Seeliger MA; Saghatelian A; Liu DR
    Nature; 2014 Jul; 511(7507):94-8. PubMed ID: 24847884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription.
    Price SR; Bailey JL; Wang X; Jurkovitz C; England BK; Ding X; Phillips LS; Mitch WE
    J Clin Invest; 1996 Oct; 98(8):1703-8. PubMed ID: 8878419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kinetic studies of insulin degrading enzyme in cultured human lymphocytes].
    Yaso S
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):289-302. PubMed ID: 3042472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle.
    Harada S; Smith RM; Smith JA; Shah N; Jarett L
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):21-8. PubMed ID: 7864812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of ubiquitin-proteasome-dependent proteolytic process in degradation of muscle protein from diabetic rabbits.
    Galban VD; Evangelista EA; Migliorini RH; do Carmo Kettelhut I
    Mol Cell Biochem; 2001 Sep; 225(1-):35-41. PubMed ID: 11716362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma.
    Baracos VE; DeVivo C; Hoyle DH; Goldberg AL
    Am J Physiol; 1995 May; 268(5 Pt 1):E996-1006. PubMed ID: 7539218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGF-I has no effect on postexercise suppression of the ubiquitin-proteasome system in rat skeletal muscle.
    Kee AJ; Taylor AJ; Carlsson AR; Sevette A; Smith RC; Thompson MW
    J Appl Physiol (1985); 2002 Jun; 92(6):2277-84. PubMed ID: 12015337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of the lysosomal, Ca2+-dependent and ubiquitin/proteasome-dependent proteolytic pathways in fast-twitch and slow-twitch rat muscle following hyperinsulinaemia.
    Larbaud D; Balage M; Taillandier D; Combaret L; Grizard J; Attaix D
    Clin Sci (Lond); 2001 Dec; 101(6):551-8. PubMed ID: 11724638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis.
    Hobler SC; Williams A; Fischer D; Wang JJ; Sun X; Fischer JE; Monaco JJ; Hasselgren PO
    Am J Physiol; 1999 Aug; 277(2):R434-40. PubMed ID: 10444550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway.
    Bailey JL; Wang X; England BK; Price SR; Ding X; Mitch WE
    J Clin Invest; 1996 Mar; 97(6):1447-53. PubMed ID: 8617877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures.
    Lynch JA; George AM; Eisenhauer PB; Conn K; Gao W; Carreras I; Wells JM; McKee A; Ullman MD; Fine RE
    J Neurosci Res; 2006 May; 83(7):1262-70. PubMed ID: 16511862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.